黄芪注射液与血栓通注射液联合应用治疗急性脑梗死的临床分析

Clinical effect of astragalus injection and xueshuantong injection in the treatment of acute cerebral infarction

目的探讨黄芪注射液与血栓通注射液联合应用于治疗急性脑梗死的临床疗效。方法选取我院在2010年1月～2013年2月收治的156例急性脑梗死患者分为对照组和观察组，对照组患者给予西药常规治疗，观察组患者在常规治疗基础上使用黄芪注射液联合血栓通注射液治疗。结果两组患者经过治疗在临床疗效、治疗前后神经功能的缺损评分上存在显著差异性（P〈0．05）。结论黄芪注射液与血栓通注射液联合应用于治疗急性脑梗死取得的临床疗效显著。

Objective To discuss the clinical effect of astragalus injection and Xueshuantong injection in the treatment of acute cerebral infarction. Methods 156 patients with acute cerebral infarction treated in this hospital from January 2010 to February 2013 were randomly divided into the control group and observation group. Patients in the control group received the routine treatment of western medicine, while patients in the observation group received the combined treatment of astragalus injection and Xueshuantong injection based upon the routine treatment. Results There was the significant difference in the clinical effect and neurologic deficit score before and after the treatment between patients in two groups （P 〈 0.05）. Conclusion There is significant clinical effect of combined astragalus injection and Xueshuantong injection in the treatment of acute cerebral infarction.